Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
4.90
-0.43 (-8.07%)
At close: Dec 29, 2023, 4:00 PM
4.91
+0.01 (0.20%)
After-hours: Dec 29, 2023, 7:33 PM EST
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for ADPT stock stock is $9.50, which predicts an increase of 93.88%. The lowest target is $6.00 and the highest is $15. On average, analysts rate ADPT stock stock as a hold.
Analyst Consensus: Hold
* Price targets were last updated on Nov 13, 2023.
Analyst Ratings
The average analyst rating for ADPT stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $6 | Buy | Maintains | $13 → $6 | +22.45% | Nov 13, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $10 | Hold | Maintains | $13 → $10 | +104.08% | Oct 24, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +165.31% | Oct 16, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +185.71% | Aug 8, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +165.31% | Aug 4, 2023 |
Financial Forecast
Revenue This Year
177.42M
from 185.31M
Decreased by -4.26%
Revenue Next Year
228.60M
from 177.42M
Increased by 28.85%
EPS This Year
-1.40
from -1.40
EPS Next Year
-1.17
from -1.40
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 194.8M | 283.0M | 335.3M |
| Avg | 177.4M | 228.6M | 299.2M |
| Low | 165.2M | 163.7M | 277.6M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 5.1% | 59.5% | 46.7% |
| Avg | -4.3% | 28.8% | 30.9% |
| Low | -10.9% | -7.8% | 21.4% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -1.24 | -1.05 | -0.60 |
| Avg | -1.40 | -1.17 | -0.84 |
| Low | -1.41 | -1.26 | -1.11 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.